Gastroenterology and Hepatology
17-32 of 35
Ross M. Maltz, MD
Shail M. Govani, MD, MSc
Nana E. Bernasko, CRNP, WHNP-BC, DNP
Shubha Bhat, PharmD, MS, BCACP
Sushila R. Dalal, MD
Jenny S. Sauk, MD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2022: A Look at Diet & Nutrition Therapies
Jennifer Caudle, DO
Maitreyi Raman , MD, MSc, FRCPC
- Crohn’s & Colitis Foundation Perspectives
Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
Charles Turck, PharmD, BCPS, BCCCP
Peter D. Higgins, MD, PhD
- Crohn’s & Colitis Foundation Perspectives
Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care
Jennifer Caudle, DO
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
Esteban Figueroa, MD
- Crohn’s & Colitis Foundation Perspectives
Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis
Jordan E. Axelrad, MD, MPH
- Crohn’s & Colitis Foundation Perspectives
Keeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes
Xiaohong Wang, MD, PhD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being
Tina Aswani Omprakash
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: The Future of IBD Treatments
Charles Turck, PharmD, BCPS, BCCCP
Siddharth Singh, MD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Challenges & Approaches to Managing IBD in the COVID-19 Era
Charles Turck, PharmD, BCPS, BCCCP
Frank Scott
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD
Charles Turck, PharmD, BCPS, BCCCP
Maria M. Oliva-Hemker, MD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Making the Most of IBD Treatment
Charles Turck, PharmD, BCPS, BCCCP
Marla C Dubinsky, MD
Stacy Kahn, MD
Jessica Allegretti, MD, MPH
